Qube Research & Technologies (QRT)
STIM icon

Qube Research & Technologies (QRT)’s Neuronetics STIM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Buy
+23,211
New +$33.8K ﹤0.01% 3177
2026
Q1 		– Sell
-108,208
Closed -$149K – 4102
2025
Q4 		$149K Buy
+108,208
New +$226K ﹤0.01% 3118
2025
Q3 		– Sell
-24,914
Closed -$87K – 3937
2025
Q2 		$87K Sell
24,914
-45,426
-65% -$179K ﹤0.01% 3057
2025
Q1 		$259K Buy
+70,340
New +$257K ﹤0.01% 2786
2024
Q3 		– Sell
-114
Closed -$205 – 4065
2024
Q2 		$205 Sell
114
-8,436
-99% -$24.3K ﹤0.01% 3390
2024
Q1 		$40.7K Buy
8,550
+8,436
+7,400% +$29.6K ﹤0.01% 3553
2023
Q4 		$331 Hold
114
– – ﹤0.01% 3949
2023
Q3 		$154 Buy
+114
New +$200 ﹤0.01% 3741
2023
Q1 		– Sell
-24,454
Closed -$168K – 3004
2022
Q4 		$168K Buy
24,454
+4,455
+22% +$21K ﹤0.01% 1867
2022
Q3 		$64K Sell
19,999
-2,686
-12% -$9.76K ﹤0.01% 2083
2022
Q2 		$73K Buy
+22,685
New +$65.9K ﹤0.01% 2043

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STIM Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Neuronetics (STIM) in Q2 2026: 23,211 shares worth $30.2K. The stake represents ﹤0.01% of the portfolio and ranks #3177 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in STIM as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in STIM in Q2 2022 and has held it in 11 quarters since. The position peaked at $259K in Q1 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Qube Research & Technologies (QRT) held 23,211 shares of Neuronetics worth $30.2K as of Q2 2026.
  • Neuronetics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3177 holding.
  • Qube Research & Technologies (QRT) first reported a position in Neuronetics in Q2 2022 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Neuronetics position peaked at $259K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.